Anti-inflammatory effects of the methanol extract of Polytrichum commune via NF-κB inactivation in RAW 264.7 macrophage cells

Biomolecules and Therapeutics

Volumn 16, Issue 4, 2008, Pages 385-393

  Cho, Woong ^a   Park, Seung Jae ^a   Shin, Ji Sun ^a   Noh, Young Su ^a   Cho, Eu Jin ^a   Nam, Jung Hwan ^a   Lee, Kyung Tae ^b  

^a Kyung Hee University   (South Korea)

^b Highland Agricultural Institute   (South Korea)

Author keywords

Anti inflammation; Cyclooxygenase 2 (COX 2); Inducible nitric oxide synthase (iNOS); Nuclear factor Kappa B (NF B); Polytrichum commune

Indexed keywords

ANTIINFLAMMATORY AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; PLANT EXTRACT; POLYTRICHUM COMMUNE EXTRACT; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOASSAY; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; ENZYME REGULATION; IMMUNOREGULATION; MACROPHAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; POLYTRICHUM COMMUNE; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REPORTER GENE;

MURINAE; POLYTRICHACEAE; POLYTRICHUM COMMUNE;

EID: 69549088093     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2008.16.4.385     Document Type: Article

References (33)

1. Aggarwal, B. B. and Natarajan, K. (1996). Tumor necrosis factors: developments during the last decade. Eur. Cytokine. Netw. 7, 93-124. (Pubitemid 26144548)
2. Burg, N. D. and Pillinger, M. H. (2001). The neutrophil: function and regulation in innate and humoral immunity. Clin. Immunol. 99, W7-17.
3. Chen, C. Y., Peng, W.H., Tsai, K. D., and Hsu, S. L. (2007). Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 81, 1602-1614
4. Dinarello, C. A. (2004). Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin. Res. 10, 201-222.
5. Doyle, S. L. and O'Neill, L. A. (2006). Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 72, 1102-1113.
6. Esser, R., Berry, C., Du, Z., Dawson, J., Fox, A., Fujimoto, R. A., Haston, W., Kimble, E. F., Koehler, J., Peppard, J., Quadros, E., Quintavalla, J., Toscano, K., Urban, L., van Duzer, J., Zhang, X., Zhou, S. and Marshall, P. J. (2005). Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br. J. Pharmacol. 144, 538-550. (Pubitemid 40349461)
7. Fang, S. H., Rao, Y. K. and Tzeng, Y. M. (2008). Anti-oxidant and inflammatory mediator's growth inhibitory effects of compounds isolated from Phyllanthus urinaria. J Ethnopharmacol. 116, 333-340.
8. Feldmann, M., Brennan, F. M., Chantry, D., Haworth, C., Turner, M., Katsikis, P., Londei, M., Abney, E., Buchan, G., Barrett, K., Corcoran, A., Kissonerghis, M., Zheng, R., Gruberck-Loebenstein, B., Barkley, D., Chu, C. Q., Field, M. and Maini R.N. (1991). Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol. Rev. 119, 105-123.
9. Gordon, S. (2007). The macrophage: past, present and future. Eur J Immunol. 37 Suppl 1, S9-17.
10. Guo, G. J. (2001). Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies. Cell. Res. 11, 85-88.
11. Hasan, A., Ahmed, L., Jay, M. and Voirin, V. (1995). Flavonoid glycosides and anthraquinone from Rumex chulepensis. Phytochemistry 39, 1211-1213.
12. Hinz, B. and Brune, K. (2002). Cyclooxygenase-2-10 years later. J. Pharmacol. Exp. Ther. 300, 367-375.
13. Iontcheva, I., Amar, S., Zawawi, K.H., Kantarci, A. and Van Dyke, T.E. (2004). Role for moesin in lipopolysaccharide-stimulated signal transduction. Infect. Immun. 72, 2312-2320. (Pubitemid 38419947)
14. Huerre, M. R. and Gounon, P. (1996). Inflammation: pattern and new concepts. Res. Immunol. 147, 417-434.
15. Inaba, H., Tagashira, M., Honma, D., Kanda, T., Kou, Y., Ohtake, Y. and Amano, A. (2008). Identification of hop polyphenolic components which inhibit prostaglandin E2 production by gingival epithelial cells stimulated with periodontal pathogen. Biol Pharm Bull. 31, 527-530.
16. Ivanova, V., Kolarova, M., Aleksieva, K., Dornberger, K. J., Haertl, A., Moellmann, U., Dahse, H. M. and Chipev N. (2007). Sanionins: anti-inflammatory and antibacterial agents with weak cytotoxicity from the Antarctic moss Sanionia georgico- uncinata. Prep. Biochem. Biotechnol. 37, 343-352. (Pubitemid 47396426)
17. Kang, Y. J., Mbonye, U. R., DeLong, C. J., Wada, M. and Smith, W. L. (2007). Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog. Lipid. Res. 46, 108-125. (Pubitemid 46661865)
18. Kim, J. B., Han, A. R., Park, E. Y., Kim, J. Y., Cho, W., Lee, J., Seo, E. K. and Lee, K.T. (2007). Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappaB inactivation in RAW 264.7 macrophage cells. Biol. Pharm. Bull. 30, 2345-2351. (Pubitemid 350223740)
19. Kim, K. S., Lee, S. H., Kang, K. H. and Kim, B. K. (2005). Flavonoid galactosides from Artemisia apiacea. Nat. Prod. Sci. 11, 10-11.
20. Krasnow, S. W., Zhang, L. Q., Leung, K. Y., Osborn, L., Kunkel, S. and Nabel, G. J. (1991). Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells. Cytokine 3, 372-379.
21. Lee, M. S., Lim, S. C. and Park, H. J. (1994). Phthalate Ester and Flavonoids Isolated From Leaves of Erythronium japonicum. Kor. J. Medicinal Crop Sci. 2, 67-72.
22. Moncada, S., Palmer, R. M. and Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
23. Nathan, C. (2002). Points of control in inflammation. Nature 420, 846-852.
24. Nimptsch, J. and Pflugmacher, S. (2008). Decomposing leaf litter: the effect of allochthonous degradation products on the antioxidant fitness and photosynthesis of Vesicularia dubyana. Ecotoxicol. Environ. Saf. 69, 541-545. (Pubitemid 351305031)
25. Park, M. H., Song, H. S., Kim, K. H., Son, D. J., Lee, S. H., Yoon, D. Y., Kim, Y., Park, I. Y., Song, S., Hwang, B. Y., Jung, J. K. and Hong, J. T. (2005). Cobrotoxin inhibits NF-kappa B activation and target gene expression through reaction with NF-kappa B signal molecules. Biochemistry 44, 8326-18236 (Pubitemid 40799913)
26. Park, J. C., Park, J. G., Hur, J. S., Choi, M. R., Yoo, E. J., Kim, S. H., Son, J. C. and Kim, M. S. (2004). Inhibitory effects of methanol extract, phenolic acids and favonoids from the leaves of Eucalyptus darylmpleana against 1,1-diphenyl-2-picrylhydrazyl radical. Nat. Prod. Sci. 10, 244-247
27. Prescott, S. M. and Fitzpatrick, F. A. (2000). Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta. 1470, M69-M78.
28. Rankin, J. A. (2004). Biological mediators of acute inflammation. AACN. Clin. Issues. 15, 3-17.
29. Smith, W., DeWitt, D. and Garavito, R. (2000). Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145-182. (Pubitemid 30792207)
30. Vane, J.R. and Botting R. M. (2003). The mechanism of action of aspirin. Thromb Res. 110, 255-258.
31. Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop- Bailey, D., Croxtall, J. and Willoughby, D. A. (1994). Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA. 91, 2046-2050 (Pubitemid 24092039)
32. Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J. and Chen, Z. J. (2001). TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351. (Pubitemid 32694385)
33. Yun, H. Y., Dawson, T. T. and Dawson T. M. (1996). Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10, 291-316.